PF-Atlas › Clinical Trials › NCT00503490

Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis

MP-376 · Phase 1

Registry ID

NCT00503490

Phase

Phase 1

Status

Completed

Drug / intervention

MP-376 (Levofloxacin solution for Inhalation)

Sponsor

Amgen

Start

2007-06

About this trial

MP-376 is evaluated in NCT00503490, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Amgen. Current status: Completed.

View NCT00503490 on ClinicalTrials.gov →

Explore related

All MP-376 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00503490 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.